Development dynamics of pharmaceutical companies in the United States of America
Abstract. The subject of this study is the economic activity of pharmaceutical companies in the USA in the period 1970-2020 as important commercial actors determining the development dynamics of healthcare and pharmaceutical markets at different hierarchical levels. On the basis of statistical and economic analysis applied within the framework of the system-historical approach, the dynamics of the average annual growth of the main indicators was studied in relation to American pharmaceutical companies` economic activity which has a global financial and commercial character. According to the obtained research results, development trends of US pharmaceutical companies as an economic phenomenon of the country`s internal development and international activity over the specified time period are identified and substantiated.
Keywords: pharmaceutical companies of the USA, "Big Pharma", US healthcare, system-historical/evolutionary approach, economic cyclicity, mergers and acquisitions of pharmaceutical companies, pharmaceutical product markets, "flexibility"/"eclecticism" of the functioning of the pharmaceutical industry
Highlights:
♦ theoretical, methodological and methodological aspects of the study of the US pharmaceutical companies activities are presented as the most important dynamic commercial actors of the global pharmaceutical market and national health care;
♦ the analysis of the American pharmaceutical companies development is carried out taking into account the dynamics of the growth of the average annual indicators of their economic activity in the US domestic market and the cyclism of the world economic patterns change;
♦ development trends of pharmaceutical companies in the USA in the period 1971-2020 as "flexible", "eclectic" phenomena of the global pharmaceutical industry development are identified and substantiated.
Valery N. Minat - Ryazan State Agrotechnological University named after P.A. Kostychev, Ryazan, Russia